ArticleFrontiers in medicine2025
Case Report: Obstructive sleep apnea syndrome-associated blood pressure fluctuations combined with simultaneous central retinal vein and artery occlusion.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: A rare case of combined branch retinal vein occlusion and branch retinal artery occlusion.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Central retinal vein occlusion (CRVO) and central retinal artery occlusion (CRAO) are serious eye blood vessel problems usually linked to heart health issues. In this case study, a patient with a diagnosis of obstructive sleep apnea syndrome (OSAS) but no traditional thrombotic or atherosclerotic risk factors experienced a rare co-occurrence of CRVO and CRAO. Case presentation: A formerly healthy 42-year-old man came with dark shadows in his right eye and acute-onset blurred vision. A thorough ophthalmic exam verified simultaneous CRVO and CRAO. Later, polysomnography showed moderate hypoxemia and severe OSAS. The patient received integrated traditional Chinese medicine, perfusion enhancement, and intraocular pressure lowering as part of multimodal therapy. With notable retinal edema resolution, post-treatment visual acuity returned to 20/20. Conclusion: Especially in patients without conventional cardiovascular risks, this case implies that OSAS might be a separate risk factor for combined CRVO and CRAO. Intermittent hypoxia, sympathetic overactivity, and hypercoagulability are probably among the underlying mechanisms. Optimizing management plans in idiopathic retinal vascular occlusions seems to depend on early OSAS screening. Moreover, this case shows the possible therapeutic benefit of combining pharmacological and conventional treatments for complicated ocular vascular disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.